Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UW Hindbrain Malformation Research Program, |
RCV000201601 | SCV000256369 | pathogenic | Joubert syndrome 5 | 2015-02-23 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000790777 | SCV000331517 | pathogenic | not provided | 2014-01-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001230296 | SCV001402771 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-07-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 166831). This premature translational stop signal has been observed in individuals with Joubert syndrome (PMID: 17564967, 28497568). This variant is present in population databases (rs727503853, gnomAD 0.001%). This sequence change creates a premature translational stop signal (p.Gln1871Valfs*2) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). |
Fulgent Genetics, |
RCV002492571 | SCV002780573 | pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2021-10-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003467210 | SCV004216750 | pathogenic | Bardet-Biedl syndrome 14 | 2022-05-06 | criteria provided, single submitter | clinical testing |